STAT proteins in cancer: orchestration of metabolism

YJ Li, C Zhang, A Martincuks, A Herrmann… - Nature reviews Cancer, 2023 - nature.com
Reprogrammed metabolism is a hallmark of cancer. However, the metabolic dependency of
cancer, from tumour initiation through disease progression and therapy resistance, requires …

Ferroptosis: mechanisms and implications for cancer development and therapy response

AF Dos Santos, G Fazeli, TNX da Silva, JPF Angeli - Trends in cell biology, 2023 - cell.com
As cancer cells develop resistance to apoptosis, non-apoptotic cell death modalities, such
as ferroptosis, have emerged as promising strategies to combat therapy-resistant cancers …

Carrier-free nanoplatform via evoking pyroptosis and immune response against breast cancer

L Li, H Tian, Z Zhang, N Ding, K He, S Lu… - … applied materials & …, 2022 - ACS Publications
Pyroptosis, as a novel mode of cell death, has been proven to have impressive antitumor
effects. Dying cells undergoing pyroptosis can elicit antitumor immunity by the release of …

Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations

KE Pendleton, K Wang, GV Echeverria - Frontiers in Cell and …, 2023 - frontiersin.org
Deregulation of tumor cell metabolism is widely recognized as a “hallmark of cancer.” Many
of the selective pressures encountered by tumor cells, such as exposure to anticancer …

The lipid metabolism remodeling: A hurdle in breast cancer therapy

Q Xiao, M Xia, W Tang, H Zhao, Y Chen, J Zhong - Cancer Letters, 2023 - Elsevier
Lipids, as one of the three primary energy sources, provide energy for all cellular life
activities. Lipids are also known to be involved in the formation of cell membranes and play …

The ACSL4 network regulates cell death and autophagy in diseases

F Chen, R Kang, J Liu, D Tang - Biology, 2023 - mdpi.com
Simple Summary ACSL4 is an enzyme involved in the intracellular conversion of long-chain
fatty acids and coenzyme A into fatty-acid coenzymes. It plays a vital role in various …

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway

SJ Oh, JY Lim, MK Son, JH Ahn, KH Song… - Nature …, 2023 - nature.com
Cisplatin resistance along with chemotherapy-induced neuropathic pain is an important
cause of treatment failure for many cancer types and represents an unmet clinical need …

Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer

R Wedam, YE Greer, DJ Wisniewski, S Weltz, M Kundu… - Cancers, 2023 - mdpi.com
Simple Summary Mitochondria, often called “the powerhouse of the cell”, generate most of
the energy required for all cellular processes. Mitochondria also provide a platform for …

Orchestral role of lipid metabolic reprogramming in T-cell malignancy

A Mehta, YK Ratre, VK Soni, D Shukla… - Frontiers in …, 2023 - frontiersin.org
The immune function of normal T cells partially depends on the maneuvering of lipid
metabolism through various stages and subsets. Interestingly, T-cell malignancies also …

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer

C Jiang, Y Zhu, H Chen, J Lin, R Xie, W Li, J Xue… - Cell Death & …, 2023 - nature.com
Tamoxifen-based endocrine therapy remains a major adjuvant therapy for estrogen receptor
(ER)-positive breast cancer (BC). However, many patients develop tamoxifen resistance …